TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Capacity to reduce dietary nitrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COMFORT Behavior Scale for Neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LATCH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hypo/hyperglycemia episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Stenting failure
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive detection rate of invasive lobular carcinoma (ILC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in staging of patients with newly diagnosed ILC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and tolerability of IMU-131
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 dose of IMU-131
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical efficacy of IMU-131
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of inspection points correctly installed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whether the restraint is installed correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ages and Stages Questionnaire (ASQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nature and frequency of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants with Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change in Brachial Artery Flow-mediated Dilation (FMD-BA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Aortic Pulse-wave Velocity (aPWV) (cm/Sec)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Subject self evaluation of training and skill
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum Observed Analyte Concentration at Steady State (Cmax,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time Zero to 24 Hours at Steady State (AUC [0-24h],ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of viable melanoma tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Participants With Grade 2 or 3 Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Intensity of dyspareunia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in worst itching intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flow-mediated vasodilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Fugl Meyer upper limb motor score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Physical Activity Behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in Healthy Eating
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Change in subjective performance on the behavioral task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Objective Comfort Assessed by Electromyography (EMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent change in wound bed surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum Osmolality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vasopressin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Recurrent trichiasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of Participants with Dose Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Navitoclax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Cmax (peak time, Tmax) of Navitoclax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Risky Sexual Behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: connectivity correlates of tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total Number of Subjects With Neoplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CHF related hospital readmissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change From Baseline in Supine Bolus Flow Time (BFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Time Curve From Time 0 to the Last Observation (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic Pressure (SP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in FACIT-F subscale scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean Trough Plasma Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Max Plasma Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD response in brain regions of interest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Movement reaction to external stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean PPD change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of BIPCV/IMX as assessed by vaccine-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: A/M2 specific immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: B/HA0 specific immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response determined by change in organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Document urological complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Quality of Life Data
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient perception of therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum Irisin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Brain-Derived Neurotrophic Factor (BDNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum Follistatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Myostatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of eligible patients enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of patients prematurely terminating treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of participants completing all study assessments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Profile of pharmacokinetics (PK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Profile of safety
Endpoint domain: Adverse events/effects
Primary endpoint: Profile of renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction of individual cumulative dose in mg cisatracurium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of healthy days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neonatal base deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyponatraemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ciliary beating frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: cAMP-dependent chloride efflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: potassium efflux
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Treatment Emergent Adverse Events and Treatment Emergent Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Had Cardiovascular Death
Endpoint domain: Mortality/survival
Primary endpoint: Mean Change From Baseline in Serum NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in knowledge regarding colorectal cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Strength of intention to be screened for colorectal cancer
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With rSBA-Antibody Titers >= 1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients that stop fulfilling fibromyalgia criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of tretinoin
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Presence, duration, and frequency of musculoskeletal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Indices of adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Benzo(a)pyrene levels in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Tobacco by-products in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnostic accuracy of coronary computed tomography angiography (CTA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bacterial Clearance Rate of Sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reliability and level of agreement between operators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Body Lean Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wender Utah Rating Scale (WURS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal Dimensions of Ablation Zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Sleep Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Safety of PTK787/ZK 222584 in combination with paclitaxel
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal percentage decrease in FEV1 after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Completion Rate of Auricular Acupuncture
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Thrombus resolution rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perception of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion with virologic suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Myocardial external energy efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Hemodynamic Derangements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants With Electrolyte Derangements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Electrophysiologic Derangements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of HIV-infected children who remain alive
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of practitioners aware of SPC statements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post Operative Nausea and Vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of oxygen use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blood iron status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in levels of circulating tumor cells (CTCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Grade 3 or greater hematologic and chemistry laboratory values, signs, or symptoms not present
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: KSHV viral gene expression in tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pharmacokinetic parameters of BAY86-9766 and its metabolite (M17)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between temperature measurement devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rate
Endpoint domain: Mortality/survival
Primary endpoint: Obtaining a glucose reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Brief Test of Adult Cognition by Telephone (BTACT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Psoriasis-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of confirmed case of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of probable case of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Failure of the repair
Endpoint domain: Adverse events/effects
Primary endpoint: Pocket Closure proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolizable Energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of low birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Prevalence of third trimester anaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of placenta malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: End-tidal concentrations of isoflurane, sevoflurane and desflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of common bile duct clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Occurrence of allopurinol-induced severe cutaneous adverse reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Fugl Meyer Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in DAS28 at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of subjects using any biologic DMARD or JAK inhibitor to Month 6
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of surgery for SBO
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of maternal subjects enrolled in the study relative to the number of pregnant women screened
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of maternal subjects, with vaginal swab samples, culture positive for GBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: GBS anti-capsular antibody concentration in maternal subjects, vaginally colonized with GBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in left atrium volume index (LAVI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline motor competence level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline stability skill level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline motor creativity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Rate for Knowledge Gaps
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence Rate for Information-seeking Behavior
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Maximum tolerated dose (MTD) of BAY2315497 injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic rate of PE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death in 36 hours
Endpoint domain: Mortality/survival
Primary endpoint: Death in 3 months
Endpoint domain: Mortality/survival
Primary endpoint: Death in 4 months
Endpoint domain: Mortality/survival
Primary endpoint: Stage of decision making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Caregiver Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of intraoperative and postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Type of resuscitation fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discomfort Intolerance Scale-Revised (DIS-R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: STAI form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in symptoms of schizophrenia (PANSS total score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in hemoglobin A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in diet quality based on the Healthy Eating Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: changes in clinic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Local recurrence of NMSC
Endpoint domain: Mortality/survival
Primary endpoint: Overall decrease in wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Echocardiographic measurements of right ventricular systolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cMRI measurements of right ventricular systolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6-minute walk distance cutoff
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain natriuretic peptide cutoff value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Social Functioning Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Patient-reported physical quality of life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Fitbit-measured Steps/Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Moderate-to-vigorous Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perfusion parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of >50% restenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Children's behavior at the dental office
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Il-17 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinician Global Improvement Scale (CGI-21)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of normalized urodynamic pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tumor Regression Grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Ferritin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of rehabilitation session without planned rest periods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of subjects with COVID-19
Endpoint domain: Mortality/survival